Daan W. Loth

ORCID: 0000-0003-1260-9326
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Asthma and respiratory diseases
  • Genetic Associations and Epidemiology
  • Epigenetics and DNA Methylation
  • Pulmonary Hypertension Research and Treatments
  • RNA modifications and cancer
  • Nutrition, Genetics, and Disease
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Obstructive Sleep Apnea Research
  • Pediatric health and respiratory diseases
  • Cardiovascular Function and Risk Factors
  • Liver Disease Diagnosis and Treatment
  • Acute Ischemic Stroke Management
  • COVID-19 Clinical Research Studies
  • Neonatal Respiratory Health Research
  • Intracerebral and Subarachnoid Hemorrhage Research
  • IL-33, ST2, and ILC Pathways
  • Liver Disease and Transplantation
  • Hepatitis C virus research
  • Frailty in Older Adults
  • Sarcoidosis and Beryllium Toxicity Research
  • Adipokines, Inflammation, and Metabolic Diseases
  • Cardiovascular Health and Disease Prevention
  • Respiratory viral infections research
  • Nutrition and Health in Aging

Amphia Ziekenhuis
2015-2025

Erasmus MC
2011-2019

Erasmus University Rotterdam
2011-2015

Dutch Health Care Inspectorate
2011-2014

The University of Western Australia
2012

Boston University
2012

María Soler Artigas Daan W. Loth Louise V. Wain Sina A. Gharib Ma’en Obeidat and 95 more Wenbo Tang Guangju Zhai Wei Zhao Albert V. Smith Jennifer E. Huffman Eva Albrecht Catherine Jackson David M. Evans Gemma Cadby Myriam Fornage Ani Manichaikul Lorna M. Lopez Toby Johnson Melinda C. Aldrich Thor Aspelund Inês Barroso Harry Campbell Patricia A. Cassano David Couper Guðný Eiríksdóttir Nora Franceschini Melissa García Christian Gieger Gauti Kjartan Gíslason Ivica Grković Christopher J. Hammond Dana B. Hancock Tamara B. Harris Adaikalavan Ramasamy Susan R. Heckbert Markku Heliövaara Georg Homuth Pirro G. Hysi Anthony James Stipan Janković Bonnie R. Joubert Stefan Karrasch Norman Klopp Beate Koch Stephen B. Kritchevsky Lenore J. Launer Yongmei Liu Laura R. Loehr Kurt Lohman Ruth J. F. Loos Thomas Lumley Khalid A Al Balushi Wei Ang R. Graham Barr John Beilby John Blakey Mladen Boban Vesna Boraska Perica Jonas Brisman John Britton Guy Brusselle Cyrus Cooper Ivan Curjuric Santosh Dahgam Ian J. Deary Shah Ebrahim Mark Eijgelsheim Clyde Francks Darya Gaysina Raquel Granell Xiangjun Gu John Hankinson Rebecca Hardy Sarah E. Harris John Henderson Amanda P. Henry Aroon D. Hingorani Albert Hofman Patrick G. Holt Jennie Hui Michael Hunter Medea Imboden Anthony James Shona M. Kerr Ivana Kolčić Florian Kronenberg Jason Z. Liu Jonathan Marchini Tricia M. McKeever Andrew D. Morris Anna-Carin Olin David J. Porteous Dirkje S. Postma Stephen S. Rich Susan M. Ring Fernando Rivadeneira Thierry Rochat Avan Aihie Sayer Ian Sayers Peter D. Sly

10.1038/ng.941 article EN Nature Genetics 2011-09-25
Daan W. Loth María Soler Artigas Sina A. Gharib Louise V. Wain Nora Franceschini and 95 more Beate Koch Tess D. Pottinger Albert V. Smith Qing Duan Christopher Oldmeadow Mi Kyeong Lee David P. Strachan Anthony James Jennifer E. Huffman Véronique Vitart Adaikalavan Ramasamy Nicholas J. Wareham Jaakko Kaprio Xin‐Qun Wang Holly Trochet Mika Kähönen Claudia Flexeder Eva Albrecht Lorna M. Lopez Kim de Jong Bharat Thyagarajan Alexessander Couto Alves Stefan Enroth Ernst Omenaas Peter K. Joshi Tove Fall Ana Viñuela Lenore J. Launer Laura R. Loehr Myriam Fornage Li Guo Jemma B. Wilk Wenbo Tang Ani Manichaikul Lies Lahousse Tamara B. Harris Kari E. North Alicja R. Rudnicka Jennie Hui Xiangjun Gu Thomas Lumley Alan F. Wright Nicholas D. Hastie Susan Campbell Rajesh Kumar Isabelle Pin Robert A. Scott Kirsi H. Pietiläinen Ida Surakka Yongmei Liu Elizabeth G. Holliday Holger Schulz Joachim Heinrich Gail Davies Judith M. Vonk Mary K. Wojczynski Anneli Pouta Åsa Johansson Sarah H. Wild Erik Ingelsson Fernando Rivadeneira Henry Völzke Pirro G. Hysi Guðný Eiríksdóttir Alanna C. Morrison Jerome I. Rotter Wei Gao Dirkje S. Postma Wendy White Stephen S. Rich Albert Hofman Thor Aspelund David Couper Lewis J. Smith Bruce M. Psaty Kurt Lohman Esteban G. Burchard André G. Uitterlinden Melissa García Bonnie R. Joubert Wendy L. McArdle AW Musk Nadia N. Hansel Susan R. Heckbert Lina Zgaga Joyce B. J. van Meurs Pau Navarro Igor Rudan Yeon‐Mok Oh Susan Redline Deborah Jarvis Jing Hua Zhao Taina Rantanen George O'connor Samuli Ripatti

10.1038/ng.3011 article EN Nature Genetics 2014-06-15

ABSTRACT Venous thromboembolism (VTE) is a common, heritable disease resulting in high rates of hospitalization and mortality. Yet few associations between VTE genetic variants, all the coagulation pathway, have been established. To identify additional determinants VTE, we conducted two‐stage genome‐wide association study (GWAS) among individuals European ancestry extended cohorts for heart aging research genomic epidemiology (CHARGE) consortium. The discovery GWAS comprised 1,618 incident...

10.1002/gepi.21731 article EN Genetic Epidemiology 2013-05-05

Forced Vital Capacity (FVC) is an important predictor of all-cause mortality in the absence chronic respiratory conditions. Epidemiological evidence highlights role early life factors on adult FVC, pointing to environmental exposures and genes affecting lung development as risk for low FVC later life. Although highly heritable, a small number have been found associated with we aimed at identifying further genetic variants by focusing genes.Per-allele effects 24,728 SNPs 403 involved were...

10.1371/journal.pone.0147388 article EN cc-by PLoS ONE 2016-02-02

Prednisone is currently recommended as the first-line treatment for pulmonary sarcoidosis but associated with many side effects. Methotrexate, which a second-line treatment, appears to have fewer effects than prednisone slower onset of action. Data are needed on efficacy and side-effect profile methotrexate compared sarcoidosis. In this multicenter, open-label, noninferiority trial involving patients who had not previously received we randomly assigned patients, in 1:1 ratio, receive or...

10.1056/nejmoa2501443 article EN New England Journal of Medicine 2025-05-18

Rationale: Chronic obstructive pulmonary disease (COPD) is an independent risk factor for ischemic stroke and the increases with severity of airflow limitation. Even though vulnerable carotid artery plaque components, such as intraplaque hemorrhage lipid core, place persons at high events, composition in patients COPD has never been explored.Objectives: To investigate prevalence wall thickening, different their relationship limitation elderly COPD.Methods: This cross-sectional analysis was...

10.1164/rccm.201206-1046oc article EN American Journal of Respiratory and Critical Care Medicine 2012-11-11

Background Pulmonary hypertension is characterized by increased pulmonary artery pressure and carries an mortality. Population-based studies into are scarce little known about its prevalence in the general population. We aimed to describe distribution of echocardiographically-assessed systolic (ePASP) population, estimate hypertension, identify associated factors. Methods Participants (n = 3381, mean age 76.4 years, 59% women) from Rotterdam Study, a population-based cohort, underwent...

10.1371/journal.pone.0130072 article EN cc-by PLoS ONE 2015-06-23

Rationale: Chronic obstructive pulmonary disease (COPD) is a common, complex multisystem in the elderly with multiple comorbidities that significantly impact morbidity and mortality. Although cerebral small-vessel an important cause of cognitive decline age-related disability, it poorly investigated potential systemic manifestation patients COPD.Objectives: To examine whether COPD relates to development location microbleeds, novel marker disease.Methods: Cross-sectional longitudinal analyses...

10.1164/rccm.201303-0455oc article EN American Journal of Respiratory and Critical Care Medicine 2013-07-25

Asthma and chronic obstructive pulmonary disease (COPD) are thought to share a genetic background ("Dutch hypothesis"). We investigated whether asthma COPD have common underlying factors, performing genome-wide association studies for both combining the results in meta-analyses. Three loci showed potential involvement diseases: chr2p24.3, chr5q23.1 chr13q14.2, containing DDX1, COMMD10 (both participating nuclear factor (NF) κβ pathway) GNG5P5, respectively. Single nucleotide polymorphisms...

10.1183/09031936.00001914 article EN European Respiratory Journal 2014-07-03

Smoking is the strongest environmental risk factor for reduced pulmonary function. The genetic component of various traits has also been demonstrated, and at least 26 loci have reproducibly associated with either FEV 1 (forced expiratory volume in second) or /FVC (FEV /forced vital capacity). Although main effects smoking are well established, question potential gene-by-smoking interaction effect remains unanswered. aim present study was to assess, using a score approach, whether these on...

10.1093/ije/dyw318 article EN cc-by International Journal of Epidemiology 2016-11-02

Treatment of pulmonary sarcoidosis is recommended in case significant symptoms, impaired or deteriorating lung function. Evidence-based treatment recommendations are limited and largely based on expert opinion. Prednisone currently the first-choice therapy leads to short-term improvement Unfortunately, prednisone often has side-effects may be associated with quality life. Methotrexate presently considered second-line therapy, appears have fewer side-effects.The primary objective this trial...

10.1186/s12890-020-01290-9 article EN cc-by BMC Pulmonary Medicine 2020-10-19

Aim β‐adrenoceptor blockers have been used with caution in patients obstructive lung diseases such as asthma or chronic pulmonary disease ( COPD ), due to the potentially increased airway reactivity and risk of bronchial obstruction. Cardioselective a more beneficial profile than non‐cardioselective can be safely prescribed both cardiovascular . We hypothesized that cardioselective also affect function. Methods This study was performed within R otterdam S tudy, prospective population‐based...

10.1111/bcp.12181 article EN British Journal of Clinical Pharmacology 2013-06-17

Background Although clopidogrel reduces the incidence of atherothrombotic events, its use is associated with an increased risk major bleeding. Cerebral microbleeds ( CMB s) are indicative subclinical microangiopathy in brain and may prelude symptomatic intracerebral hemorrhage. We examined association between s persons without a history stroke. Methods Results performed cross‐sectional analysis using data from Rotterdam Study, prospective population‐based cohort aged 45 years older. Among...

10.1161/jaha.113.000359 article EN cc-by-nc-nd Journal of the American Heart Association 2013-09-26

Chronic respiratory disorders are important contributors to the global burden of disease. Genome-wide association studies (GWASs) lung function measures have identified several trait-associated loci, but explain only a modest portion phenotypic variability. We postulated that integrating pathway-based methods with GWASs pulmonary and airflow obstruction would identify broader repertoire genes processes influencing these traits. performed two independent applied gene set enrichment analysis...

10.1093/hmg/ddv378 article EN Human Molecular Genetics 2015-09-22
Coming Soon ...